TP53 andMYC gene alterations independently predict poor prognosis in breast cancer patients

MLA

Jan G. M. Klijn, et al. “TP53 AndMYC Gene Alterations Independently Predict Poor Prognosis in Breast Cancer Patients.” Genes, Chromosomes and Cancer, vol. 16, July 1996, pp. 170–79. EBSCOhost, https://doi.org/10.1002/(sici)1098-2264(199607)16:3<170::aid-gcc3>3.0.co;2-w.

APA

Jan G. M. Klijn, Wim L. J. van Putten, John A. Foekens, Iris L. van Staveren, Els M.J.J. Berns, Maxime P. Look, & Marcel Smid. (1996). TP53 andMYC gene alterations independently predict poor prognosis in breast cancer patients. Genes, Chromosomes and Cancer, 16, 170–179. https://doi.org/10.1002/(sici)1098-2264(199607)16:3<170::aid-gcc3>3.0.co;2-w

Chicago

Jan G. M. Klijn, Wim L. J. van Putten, John A. Foekens, Iris L. van Staveren, Els M.J.J. Berns, Maxime P. Look, and Marcel Smid. 1996. “TP53 AndMYC Gene Alterations Independently Predict Poor Prognosis in Breast Cancer Patients.” Genes, Chromosomes and Cancer 16 (July): 170–79. doi:10.1002/(sici)1098-2264(199607)16:3<170::aid-gcc3>3.0.co;2-w.